Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

PubWeight™: 3.29‹?› | Rank: Top 1%

🔗 View Article (PMID 20121738)

Published in Am J Transplant on January 29, 2010

Authors

B Sis1, M Mengel, M Haas, R B Colvin, P F Halloran, L C Racusen, K Solez, W M Baldwin, E R Bracamonte, V Broecker, F Cosio, A J Demetris, C Drachenberg, G Einecke, J Gloor, D Glotz, E Kraus, C Legendre, H Liapis, R B Mannon, B J Nankivell, V Nickeleit, J C Papadimitriou, P Randhawa, H Regele, K Renaudin, E R Rodriguez, D Seron, S Seshan, M Suthanthiran, B A Wasowska, A Zachary, A Zeevi

Author Affiliations

1: Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. bsis@ualberta.ca

Associated clinical trials:

Bortezomib in Late Antibody-mediated Kidney Transplant Rejection (BORTEJECT) | NCT01873157

Articles citing this

(truncated to the top 100)

Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45

The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med (2014) 2.38

Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol (2010) 2.32

Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28

Pros and cons for C4d as a biomarker. Kidney Int (2012) 2.03

The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant (2011) 1.98

Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J Am Soc Nephrol (2014) 1.78

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol (2012) 1.71

Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant (2010) 1.55

Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy. Clin J Am Soc Nephrol (2012) 1.46

Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens (2012) 1.46

Platelets in early antibody-mediated rejection of renal transplants. J Am Soc Nephrol (2014) 1.41

Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant (2014) 1.29

Antibodies in transplantation. Discov Med (2010) 1.18

Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med (2014) 1.14

Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev (2012) 1.11

Management of polyomavirus-associated nephropathy in renal transplant recipients. Nat Rev Nephrol (2012) 1.10

Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction. J Am Soc Nephrol (2014) 1.03

ABO incompatible renal transplants: Good or bad? World J Transplant (2014) 0.97

Quantitative elastography of renal transplants using supersonic shear imaging: a pilot study. Eur Radiol (2012) 0.97

Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PLoS One (2013) 0.97

Follicular T helper cells and humoral reactivity in kidney transplant patients. Clin Exp Immunol (2015) 0.96

Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders? Curr Opin Organ Transplant (2012) 0.96

Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. Clin J Am Soc Nephrol (2012) 0.95

Isolated endarteritis and kidney transplant survival: a multicenter collaborative study. J Am Soc Nephrol (2014) 0.94

Pathologic findings in lung allografts with anti-HLA antibodies. J Heart Lung Transplant (2013) 0.93

Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival. J Am Soc Nephrol (2015) 0.92

The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant (2012) 0.91

What is the best way to measure renal fibrosis?: A pathologist's perspective. Kidney Int Suppl (2011) (2014) 0.90

Nox2 is a mediator of chronic CsA nephrotoxicity. Am J Transplant (2012) 0.90

The complement cascade and renal disease. Arch Immunol Ther Exp (Warsz) (2013) 0.90

The clinical impact of humoral immunity in pediatric renal transplantation. J Am Soc Nephrol (2013) 0.89

The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy. Clin J Am Soc Nephrol (2013) 0.89

Accommodation in renal transplantation: unanswered questions. Curr Opin Organ Transplant (2010) 0.87

DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients. PLoS One (2012) 0.86

Neutrophils: game changers in glomerulonephritis? Trends Mol Med (2010) 0.86

Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited. Transplantation (2012) 0.85

Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts. Am J Transplant (2014) 0.84

Human leukocyte antigen antibody incompatible renal transplantation. Indian J Nephrol (2012) 0.83

Advances of genomic science and systems biology in renal transplantation: a review. Semin Immunopathol (2011) 0.83

Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients. Transplantation (2014) 0.83

Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection. Clin J Am Soc Nephrol (2015) 0.83

Assessment of kidney organ quality and prediction of outcome at time of transplantation. Semin Immunopathol (2011) 0.82

The involvement of SMILE/TMTC3 in endoplasmic reticulum stress response. PLoS One (2011) 0.82

Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody. Clin Kidney J (2012) 0.82

CD28 family and chronic rejection: "to belatacept...And beyond!". J Transplant (2012) 0.82

Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients. Kidney Int (2013) 0.82

Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation. Clin Dev Immunol (2013) 0.82

Early steroid withdrawal in pediatric renal transplant: five years of follow-up. Pediatr Nephrol (2011) 0.82

Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation. Front Immunol (2015) 0.81

Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft Survival. J Am Soc Nephrol (2015) 0.81

Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens. J Am Soc Nephrol (2015) 0.81

Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes. J Transplant (2012) 0.81

Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction. Am J Transplant (2014) 0.80

Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation. Fibrogenesis Tissue Repair (2014) 0.80

Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation. Am J Transplant (2014) 0.80

MHC class I signaling: new functional perspectives for an old molecule. Tissue Antigens (2014) 0.80

Noninvasive prognostication of polyomavirus BK virus-associated nephropathy. Transplantation (2013) 0.80

The tacrolimus metabolism rate influences renal function after kidney transplantation. PLoS One (2014) 0.80

Excellent long-term outcome of renal transplantation in cystinosis patients. Orphanet J Rare Dis (2015) 0.80

Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. World J Nephrol (2015) 0.80

The specificity of acute and chronic microvascular alterations in renal allografts. Clin Transplant (2013) 0.79

Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients. Pediatr Nephrol (2016) 0.79

Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. Am J Transplant (2015) 0.79

Urinary calprotectin and posttransplant renal allograft injury. PLoS One (2014) 0.79

Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. Transplantation (2011) 0.79

Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine. Am J Transplant (2010) 0.79

Acute transplant glomerulopathy with monocyte rich infiltrate. Transpl Immunol (2013) 0.79

The Banff 2015 Kidney meeting report: Current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant (2016) 0.78

Antibody-Mediated Lung Transplant Rejection. Curr Respir Care Rep (2012) 0.78

Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection. Transpl Int (2012) 0.78

Transplant renal artery stenosis in children: risk factors and outcome after endovascular treatment. Pediatr Nephrol (2013) 0.78

Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions. J Am Soc Nephrol (2014) 0.78

Histopathological and clinical findings in renal transplants with Banff type II and III acute cellular rejection without tubulointerstitial infiltrates. Virchows Arch (2013) 0.78

Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection. Transplantation (2012) 0.78

Top Differential Diagnosis Should Be Microscopic Polyangiitis in ANCA-Positive Patient with Diffuse Pulmonary Hemorrhage and Hemosiderosis. Case Rep Pathol (2014) 0.77

Expression of decoy receptor 3 in kidneys is associated with allograft survival after kidney transplant rejection. Sci Rep (2015) 0.77

Acute and chronic antibody-mediated rejection in pediatric kidney transplantation. Pediatr Nephrol (2014) 0.77

Immunologic monitoring in kidney transplant recipients. Kidney Res Clin Pract (2013) 0.77

Characterization of antigen-specific B cells using nominal antigen-coated flow-beads. PLoS One (2013) 0.77

Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging Technique. J Am Soc Nephrol (2015) 0.77

Characteristics of alloreactive T cells measured before renal transplantation. Clin Exp Immunol (2012) 0.77

A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts. PLoS One (2015) 0.77

Nephrectomy for the failed renal allograft in children: predictors and outcomes. Pediatr Nephrol (2013) 0.77

Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies. Transplantation (2017) 0.77

Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy. World J Transplant (2014) 0.77

The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria. PLoS One (2012) 0.76

TSI ultrasound elastography for the diagnosis of chronic allograft nephropathy in kidney transplanted patients. J Ultrason (2013) 0.76

Capillary dilation and rarefaction are correlated with intracapillary inflammation in antibody-mediated rejection. J Immunol Res (2014) 0.76

Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantation. PLoS One (2013) 0.76

Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. Clin J Am Soc Nephrol (2014) 0.76

Complement cascade and kidney transplantation: The rediscovery of an ancient enemy. World J Transplant (2014) 0.76

Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation. PLoS One (2016) 0.76

Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal disease. Am J Transplant (2013) 0.76

Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step. J Immunol Res (2017) 0.75

Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation. PLoS One (2015) 0.75

Surveillance biopsies in children post-kidney transplant. Pediatr Nephrol (2011) 0.75

Pathological diagnosis of antibody-mediated rejection in renal allograft without c4d staining, how much reliable? Adv Biomed Res (2012) 0.75

Renal allograft rejection: pieces of the puzzle. J Am Soc Nephrol (2014) 0.75

Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis. Transplant Direct (2017) 0.75

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09

Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest (1981) 6.89

The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol (1996) 6.62

A common precursor for hematopoietic and endothelial cells. Development (1998) 6.58

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Liver transplantation (1). N Engl J Med (1989) 4.53

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature (1999) 3.93

Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest (1996) 3.73

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet (1996) 3.48

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med (2001) 3.16

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11

Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol (2002) 3.05

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Gastrointestinal abnormalities in children with autistic disorder. J Pediatr (1999) 2.96

Optimization of initial tacrolimus dose using pharmacogenetic testing. Clin Pharmacol Ther (2010) 2.94

Liver transplantation (2). N Engl J Med (1989) 2.93

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res (1997) 2.91